Aidi H. Gao
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Correction: TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.
Journal: Cell death & disease
Published: December 23, 2025
CD70 regulates the NF1/Ras/ERK axis to promote metastatic potential in clear cell renal cell carcinoma.
Journal: Cancer cell international
Published: October 12, 2025
TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification.
Journal: Cell death & disease
Published: November 14, 2024
TMT-Based Quantitative Proteomic Profiling of Human Esophageal Cancer Cells Reveals the Potential Mechanism and Potential Therapeutic Targets Associated With Radioresistance.
Journal: Proteomics. Clinical applications
Published: February 04, 2024
DNA polymerase iota promotes EMT and metastasis of esophageal squamous cell carcinoma by interacting with USP7 to stabilize HIF-1α.
Journal: Cell death & disease
Published: May 16, 2023
Correction: TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.
Journal: Cell death & disease
Published: April 14, 2023
Polymerase iota (POLI) confers radioresistance of esophageal squamous cell carcinoma by regulating RAD51 stability and facilitating homologous recombination.
Journal: Cell death discovery
Published: April 13, 2023
TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.
Journal: Cell death & disease
Published: June 20, 2022
RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs.
Journal: Cancer medicine
Published: December 06, 2021
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 21, 2021
Last Updated: 09/26/2026